Concepedia

Douglas Kramer

DK

3

Publications

34

Citations

3

H-Index

2017

Active since

Affiliations

Athenex (United States)(Current)

Taipei Medical University-Shuang Ho Hospital

Tri-Service General Hospital

University of Otago

Douglas Kramer is an author at Athenex (United States) specializing in oncology, cancer therapeutics, and quantitative pharmacology.

Top concepts

Publications per year

2017–2021

3

Publications

3

Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study

Christopher Jackson, Tak Hung, Eva Segelov et al. · British Journal of Clinical Pharmacology · 2021 · 13 citations · Full text

Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients.

Ming‐Shen Dai, T.H. Chao, Chang-Fan Chiu et al. · Journal of Clinical Oncology · 2019 · 11 citations

, , +10

A phase 1b dose escalation study to evaluate safety, tolerability and pharmacokinetics of oral monotherapy with KX2-391 in elderly subjects with acute myeloid leukemia who are refractory to or have declined standard induction therapy.

Margaret Kasner, Ellen K. Ritchie, David L. Cutler et al. · Journal of Clinical Oncology · 2017 · 10 citations

Rows per page

1–3 of 3